Chen S - Search Results

1

Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer.

Zhao ZR, Yang CP, Chen S, Yu H, Lin YB, Lin YB, Qi H, Jin JT, Lian SS, Wang YZ, You JQ, Zhai WY, Long H. Zhao ZR, et al. Among authors: chen s. Oncoimmunology. 2021 Oct 25;10(1):1996000. doi: 10.1080/2162402X.2021.1996000. eCollection 2021. Oncoimmunology. 2021. PMID: 34712513 Free PMC article. Clinical Trial.

2

Novel prognostic model for stratifying survival in stage I lung adenocarcinoma patients.

Liu DH, Ye ZH, Chen S, Sun XS, Hou JY, Zhao ZR, Long H. Liu DH, et al. Among authors: chen s. J Cancer Res Clin Oncol. 2020 Mar;146(3):801-807. doi: 10.1007/s00432-019-03110-y. Epub 2019 Dec 28. J Cancer Res Clin Oncol. 2020. PMID: 31884561 Free PMC article.

3

[Application of Neoadjuvant Immuno-chemotherapy in NSCLC].

Chen S, Zhao Z, Long H. Chen S, et al. Zhongguo Fei Ai Za Zhi. 2021 Apr 20;24(4):284-292. doi: 10.3779/j.issn.1009-3419.2021.102.10. Zhongguo Fei Ai Za Zhi. 2021. PMID: 33910277 Free PMC article. Review. Chinese.

4

A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.

Zhai WY, Duan FF, Chen S, Wang JY, Lin YB, Wang YZ, Rao BY, Zhao ZR, Long H. Zhai WY, et al. Among authors: chen s. Front Genet. 2022 Jan 5;12:798131. doi: 10.3389/fgene.2021.798131. eCollection 2021. Front Genet. 2022. PMID: 35069695 Free PMC article.

5

Zhai WY, Duan FF, Chen S, Wang JY, Zhao ZR, Wang YZ, Rao BY, Lin YB, Long H. Zhai WY, et al. Among authors: chen s. Front Cell Dev Biol. 2022 Mar 1;10:770550. doi: 10.3389/fcell.2022.770550. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35300428 Free PMC article.

6

Integrative Analysis of Bioinformatics and Machine Learning Algorithms Identifies a Novel Diagnostic Model Based on Costimulatory Molecule for Predicting Immune Microenvironment Status in Lung Adenocarcinoma.

Zhai WY, Duan FF, Wang YZ, Wang JY, Zhao ZR, Lin YB, Rao BY, Chen S, Zheng L, Long H. Zhai WY, et al. Among authors: chen s. Am J Pathol. 2022 Oct;192(10):1433-1447. doi: 10.1016/j.ajpath.2022.06.015. Epub 2022 Aug 7. Am J Pathol. 2022. PMID: 35948079 Free article.

7

Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma.

Zhai W, Chen S, Duan F, Wang J, Zhao Z, Lin Y, Rao B, Wang Y, Zheng L, Long H. Zhai W, et al. Among authors: chen s. Cancer Med. 2023 Feb;12(4):4968-4980. doi: 10.1002/cam4.5190. Epub 2022 Sep 3. Cancer Med. 2023. PMID: 36056909 Free PMC article.

8

Response of primary tumor and lymph node in non-small cell lung cancer after neoadjuvant immunotherapy: a pooled analysis.

Zhai WY, Zhao ZR, Chen S, Yu H, Lin YB, Wang YZ, Long H. Zhai WY, et al. Among authors: chen s. J Immunother Cancer. 2022 Sep;10(9):e005160. doi: 10.1136/jitc-2022-005160. J Immunother Cancer. 2022. PMID: 36109085 Free PMC article.

9

Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study.

Liu DH, Zhou XY, Pan YG, Chen S, Ye ZH, Chen GD. Liu DH, et al. Among authors: chen s, chen gd. Cancer Med. 2020 Feb;9(4):1287-1297. doi: 10.1002/cam4.2785. Epub 2019 Dec 20. Cancer Med. 2020. PMID: 31859464 Free PMC article.

10

High serum fibroblast growth factor 21 is associated with inferior hepatocellular carcinoma survival: A prospective cohort study.

Liu ZY, Luo Y, Fang AP, Wusiman M, He TT, Liu XZ, Yishake D, Chen S, Lu XT, Zhang YJ, Zhu HL. Liu ZY, et al. Among authors: chen s. Liver Int. 2022 Mar;42(3):663-673. doi: 10.1111/liv.15100. Epub 2021 Dec 3. Liver Int. 2022. PMID: 34812573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81,395 results

Search Page